Diagnostic and Biotech

Europe Genome Editing Market to 2025 - Regional Analysis and Forecasts by Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), Antisense RNA and Others), Application (Genetic Engineering, Cell Line Engineering and Others) End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes), and Country

  • THE3207019
  • 145 Pages
  • April 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The Europe genome editing market is expected to reach US$ 3,421.1 Mn in 2025 from US$ 1,052.9 Mn in 2017. The market is estimated to grow with a CAGR of 16.7% from 2018-2025.

The growth of the genome editing market is primarily attributed to the rise in the advancements for genome editing technologies and technological developments in genomics. However, European Court of Justice ruling on genome editing and nonexistence of skilled professionals are likely to pose a negative impact on the market growth. On the other hand, scopes for the consumer genomics is likely to have a positive impact on the growth of the Europe genome editing market in the coming years.

The biotechnological field is characterized as a continuously developing the technologies for the betterment of the health for all the living organisms. Therefore, the technologies for the genome editing is undergoing various advancements, the most recent advancement for the genome editing is utilizing the nucleases which include the zinc finger nuclease (ZFN), transcription activators like effector nuclease (TALEN) and (clustered regulatory interspaced short palindromic repeats) CRISPR Cas9 system. The technologies has been successfully implemented in the several crops, including the Solanaceae plants, such as tomato, potato, tobacco, and petunia. CRISPR Case 9 among the three nucleases is the best for breeding, crop improvement, and the functional analysis of genes of interest. The technology is best due to its simplicity and high efficiency.

The technological advancements are being carried out by most of the biotechnological companies. The companies are continuously involved in the research and development for the technologies and producing the products for the genome editing. In addition, most of the start-up companies are involved in the development of the genome editing tools and services. For instance, UK based company, Horizon Discovery have discovered cell lines, the company has utilized the ability of the rAAV's to amplify the cell's own high fidelity DNA repair pathway. The cell lines created consists of the precisely engineered, disease that are associated with mutations for the most widely studied oncology genes, such as KRAS, PIK3CA and BRAF. Moreover, the company is also license out its nuclease-based genome editing technologies to improve our efficiencies still further at first Zinc Finger Nucleases (ZFNs), and then CRISPR Cas9 gene editing. Thus, the technological advancement for genome editing tools by the market players and the start-up companies are likely to drive the market for the genome editing market in the forecast period.

In 2017, the CRISPR segment segment held a largest market share of 53.6% of the genome editing market, by technology. This segment is also expected to dominate the market in 2025 owing to the simple, fast and accurate property of the CRISPR. Moreover, the TALENs segment is anticipated to witness the significant growth rate of 16.6% during the forecast period, 2018 to 2025 owing to the properties provided by the TALENs the market for it is expected to rise in the coming near future.

Europe genome editing market, based on application was segmented into genetic engineering, cell line engineering and others. The cell line engineering segment is anticipated to grow at a CAGR of 17.5% during the forecast period. Moreover, the genetic engineering segment is expected to grow at the significant rate during the coming years owing to its sub segments such as animal genetic engineering and plant genetic engineering that are being carried out extensively. In 2017, the biotechnology & pharmaceutical companies segment held a largest market share of 61.2% of the genome editing market, by end user. This segment is also expected to dominate the market in 2025 owing to the advantages of the CRISPR, the companies have enhanced their research and development for the drug discoveries that can treat various diseases. Hence, the market is likely to propel in the coming years.

Some of the major primary and secondary sources for genome editing included in the report are, Contract Research Organizations (CRO), United States Department of Agriculture (USDA), National Institutes of Health (NIH), Abu Dhabi Fund for Development (ADFD), Ministry of Science and Technology (MST), International Service For The Acquisition Of Agri-Biotech Applications (ISAAA), Food and Drug Administration (FDA), Department of Biotechnology (DBT) and others.

TABLE OF CONTENTS

PART 1. INTRODUCTION

1.1 SCOPE OF THE STUDY

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

PART 2. EUROPE GENOME EDITING TESTING MARKET - KEY TAKEAWAYS

PART 3. EUROPE GENOME EDITING MARKET - MARKET LANDSCAPE

3.1 OVERVIEW

3.2 MARKET SEGMENTATION

3.2.1 Europe Genome Editing Market - By Technology

3.2.2 Europe Genome Editing Market - By Application

3.2.3 Europe Genome Editing Market - By End User

3.2.4 Europe Genome Editing Market - By Country

3.3 PEST ANALYSIS

PART 4. EUROPE GENOME EDITING MARKET- KEY MARKET DYNAMICS

4.1 KEY MARKET DRIVERS

4.1.1 Rise in the Advancements For Genome Editing Technologies

4.1.2 Technological Developments in Genomics

4.2 KEY MARKET RESTRAINTS

4.2.1 European Court of Justice Ruling on Genome Editing

4.2.2 Nonexistence of Skilled Professionals

4.3 KEY MARKET OPPORTUNITIES

4.3.1 Scopes for the Consumer Genomics

4.4 FUTURE TRENDS

4.4.1 Technologies of Gene Editing

4.5 IMPACT ANALYSIS

PART 5. GENOME EDITING MARKET - EUROPE ANALYSIS

5.1 EUROPE GENOME EDITING MARKET REVENUE FORECASTS AND ANALYSIS

5.2 MARKET POSITIONING

5.3 PERFORMANCE OF KEY PLAYERS

5.4 EXPERT OPINIONS

PART 6. EUROPE GENOME EDITING MARKET ANALYSIS - BY TECHNOLOGY

6.1 OVERVIEW

6.2 EUROPE GENOME EDITING MARKET, BY TECHNOLOGY, 2017 & 2025 (%)

6.3 EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

6.4 TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) MARKET

6.4.1 Overview

6.4.2 Europe Transcription Activator-Like Effector Nucleases (TALENS) Market Revenue and Forecasts to 2025 (US$ Mn)

6.5 CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET

6.5.1 Overview

6.5.2 Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Market Revenue and Forecasts to 2025 (US$ Mn)

6.6 ZINC FINGER NUCLEASES (ZFNS) MARKET

6.6.1 Overview

6.6.2 Europe Zinc Finger Nucleases (ZFNs) Market Revenue and Forecasts to 2025 (US$ Mn)

6.7 ANTISENSE RNA MARKET

6.7.1 Overview

6.7.2 Europe Antisense RNA Market Revenue and Forecasts to 2025 (US$ Mn)

6.8 OTHERS MARKET

6.8.1 Overview

6.8.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 7. EUROPE GENOME EDITING MARKET ANALYSIS - BY APPLICATION

7.1 OVERVIEW

7.2 EUROPE GENOME EDITING MARKET, BY APPLICATION, 2017 & 2025 (%)

7.3 EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

7.4 GENETIC ENGINEERING MARKET

7.4.1 Overview

7.4.2 Europe Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.4.3 Animal Genetic Engineering Market

7.4.3.1 Overview

7.4.3.2 Europe Animal Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.4.4 Plant Genetic Engineering Market

7.4.4.1 Overview

7.4.4.2 Europe Plant Genetic Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.5 CELL LINE ENGINEERING MARKET

7.5.1 Overview

7.5.2 Europe Cell Line Engineering Market Revenue and Forecasts to 2025 (US$ Mn)

7.6 OTHERS MARKET

7.6.1 Overview

7.6.2 Europe Others Market Revenue and Forecasts to 2025 (US$ Mn)

PART 8. EUROPE GENOME EDITING MARKET ANALYSIS - BY END USER

8.1 OVERVIEW

8.2 EUROPE GENOME EDITING MARKET, BY END USER, 2017 & 2025 (%)

8.3 EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

8.4 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET

8.4.1 Overview

8.4.2 Europe Biotechnology & Pharmaceutical Companies Market Revenue and Forecasts to 2025 (US$ Mn)

8.5 ACADEMIC & GOVERNMENT RESEARCH ORGANIZATIONS MARKET

8.5.1 Overview

8.5.2 Europe Academic & Government Research Organizations Market Revenue and Forecasts to 2025 (US$ Mn)

8.6 CONTRACT RESEARCH ORGANIZATION MARKET

8.6.1 Overview

8.6.2 Europe Contract Research Organization Market Revenue and Forecasts to 2025 (US$ Mn)

PART 9. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025

9.1 OVERVIEW

9.2 EUROPE GENOME EDITING TESTING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.3 EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

9.4 EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

9.4.1 Europe Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.5 EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

9.6 EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

9.7 UK GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.7.1 UK Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)

9.7.2 UK Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

9.7.3 UK Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.7.3.1 UK Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.7.4 UK Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)

9.8 GERMANY GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.8.1 Germany Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)

9.8.2 Germany Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

9.8.3 Germany Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.8.3.1 Germany Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.8.4 Germany Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)

9.9 FRANCE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

9.9.1 France Genome Editing Market Revenue and Forecasts to 2025 (US$ Mn)

9.9.2 France Genome Editing Market Revenue And Forecasts to 2025, By Technology (US$ Mn)

9.9.3 France Genome Editing Market Revenue And Forecasts to 2025, By Application (US$ Mn)

9.9.3.1 France Genetic Engineering Market Revenue And Forecasts to 2025, By Type (US$ Mn)

9.9.4 France Genome Editing Market Revenue And Forecasts to 2025, By End User (US$ Mn)

PART 10. GENOME EDITING MARKET-KEY COMPANY PROFILES

10.1 THERMO FISHER SCIENTIFIC INC.

10.1.1 Key Facts

10.1.2 Business Description

10.1.3 Financial Overview

10.1.4 Product Portfolio

10.1.5 SWOT Analysis

10.1.6 Key Developments

10.2 INTEGRATED DNA TECHNOLOGIES, INC.

10.2.1 Key Facts

10.2.2 Business Description

10.2.3 Financial Overview

10.2.4 Product Portfolio

10.2.5 SWOT Analysis

10.2.6 Key Developments

10.3 MERCK KGAA

10.3.1 Key Facts

10.3.2 Business Description

10.3.3 Financial Overview

10.3.4 Product Portfolio

10.3.5 SWOT ANALYSIS

10.3.6 KEY DEVELOPMENTS

10.4 LONZA

10.4.1 Key Facts

10.4.2 Business Description

10.4.3 Financial Overview

10.4.4 Product Portfolio

10.4.5 SWOT Analysis

10.4.6 Key Developments

10.5 NEW ENGLAND BIOLABS

10.5.1 Key Facts

10.5.2 Business Description

10.5.3 Financial Overview

10.5.4 Product Portfolio

10.5.5 SWOT Analysis

10.5.6 Key Developments

10.6 GENSCRIPT

10.6.1 Key Facts

10.6.2 Business Description

10.6.3 Financial Overview

10.6.4 Product Portfolio

10.6.5 SWOT Analysis

10.6.6 Key Developments

10.7 TRANSPOSAGEN BIOPHARMACEUTICALS, INC.

10.7.1 Key Facts

10.7.2 Business Description

10.7.3 Financial Overview

10.7.4 Product/ Services Portfolio

10.7.5 SWOT Analysis

10.7.6 Key Developments

10.8 HORIZON DISCOVERY GROUP PLC

10.8.1 Key Facts

10.8.2 Business Description

10.8.3 Financial Overview

10.8.4 Product/ Services Portfolio

10.8.5 SWOT Analysis

10.8.6 Key Developments

10.9 SANGAMO THERAPEUTICS, INC.

10.9.1 Key Facts

10.9.2 Business Description

10.9.3 Financial Overview

10.9.4 Product Portfolio

10.9.5 SWOT Analysis

10.9.6 Key Developments

10.10 EDITAS MEDICINE

10.10.1 Key Facts

10.10.2 Business Description

10.10.3 Financial Overview

10.10.4 Service Portfolio

10.10.5 SWOT Analysis

10.10.6 Key Developments

PART 11. APPENDIX

11.1 ABOUT THE INSIGHT PARTNERS

11.2 GLOSSARY OF TERMS

11.3 METHODOLOGY

11.3.1 Coverage

11.3.2 Secondary Research

11.3.3 Primary Research

LIST OF TABLES

TABLE 1. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 2. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 3. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 4. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 5. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 6. EUROPE GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 7. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 8. UK GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 9. UK GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 10. UK GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 11. UK GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 12. GERMANY GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 13. GERMANY GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 14. GERMANY GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 15. GERMANY GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 16. FRANCE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY TECHNOLOGY (US$ MN)

TABLE 17. FRANCE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY APPLICATION (US$ MN)

TABLE 18. FRANCE GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN)

TABLE 19. FRANCE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY END USER (US$ MN)

TABLE 20. GLOSSARY OF TERMS, GENOME EDITING MARKET

LIST OF FIGURES

FIGURE 1. GERMANY GENOME EDITING MARKET, REVENUE (US$ MN), BY COUNTRY 2018 & 2025

FIGURE 2. EUROPE GENOME EDITING MARKET BY TYPE, MARKET SHARE (%), 2017

FIGURE 3. EUROPE GENOME EDITING MARKET BY SERVICES, MARKET SHARE (%), 2017

FIGURE 4. EUROPE GENOME EDITING MARKET BY END USER, MARKET SHARE (%), 2017

FIGURE 5. GENOME EDITING MARKET SEGMENTATION

FIGURE 6. EUROPE PEST ANALYSIS

FIGURE 7. GENOME EDITING MARKET IMPACT ANALYSIS OF DRIVERS & RESTRAINTS

FIGURE 8. EUROPE GENOME EDITING MARKET - REVENUE FORECASTS AND ANALYSIS - 2017- 2025

FIGURE 9. EUROPE GENOME EDITING MARKET, BY TECHNOLOGY, 2017 & 2025 (%)

FIGURE 10. EUROPE TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASES (TALENS) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 11. EUROPE CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS (CRISPR) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 12. EUROPE ZINC FINGER NUCLEASES (ZFNS) MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 13. EUROPE ANTISENSE RNA MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 14. EUROPE OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 15. EUROPE GENOME EDITING MARKET BY APPLICATION, 2017 & 2025 (%)

FIGURE 16. EUROPE GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 17. EUROPE ANIMAL GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 18. EUROPE PLANT GENETIC ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 19. EUROPE CELL LINE ENGINEERING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 20. EUROPE OTHERS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 21. EUROPE GENOME EDITING MARKET BY END USER, 2017 & 2025 (%)

FIGURE 22. EUROPE BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 23. EUROPE ACADEMIC & GOVERNMENT RESEARCH ORGANIZATIONS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 24. EUROPE CONTRACT RESEARCH ORGANIZATION MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 25. EUROPE GENOME EDITING MARKET REVENUE OVERVIEW, BY COUNTRY, 2017 (US$ MN)

FIGURE 26. EUROPE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 27. EUROPE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%)

FIGURE 28. UK GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 29. GERMANY GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

FIGURE 30. FRANCE GENOME EDITING MARKET REVENUE AND FORECASTS TO 2025 (US$ MN)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370